成都欧林生物科技股份有限公司 关于获得政府补助的公告

Group 1 - The company received a total government subsidy of RMB 4.64 million for its project on the development and industrialization of a vaccine for methicillin-resistant Staphylococcus aureus [1] - Of the total subsidy, RMB 3.248 million is allocated to the company, while RMB 1.392 million is for the project partner [1] - The government subsidy received by the company is classified as a revenue-related subsidy, and its impact on the company's profit for the current and future years is uncertain until project completion and acceptance [1]